ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1732

The Characteristic T-Cell Receptor-Mediated Signaling of Peripheral Blood T Cells in Dermatomyositis and Polymyositis

Yasuhiro Shimojima1, Dai Kishida2 and Yoshiki Sekijima2, 1Department of Medicine (Neurology and Rheumatology), Shinshu University School of Medicine, Matsumoto, Japan, 2Department of Medicine (Neurology and Rheumatology), Shinshu University School of Medicine, Matsumoto, Japan

Meeting: 2017 ACR/ARHP Annual Meeting

Date of first publication: September 18, 2017

Keywords: dermatomyositis, polymyositis and signal transduction, T cells

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 6, 2017

Title: T Cell Biology and Targets in Autoimmune Disease Poster I

Session Type: ACR Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose: In dermatomyositis (DM) and polymyositis (PM), the characteristics of T cell expression in peripheral blood have been previously described; especially, decreased expression of interferon-γ (IFN-γ) and interleukin-17 (IL-17) producing CD4+ T cells was significantly demonstrated in the acute phase of DM. However, the mechanism underlying the decrease in circulating IFN-γ and IL-17 producing CD4+ T cell expression is still unknown. The purpose of this study was to investigate the T-cell receptor (TCR)-mediated intracellular signaling in peripheral blood T cells in DM and PM.

Methods: Peripheral blood T cells from 86 patients with DM (n = 57) and PM (n = 29), as well as from 28 healthy controls, were used for experimental investigations. T-cell subtypes and TCR-induced phosphorylated zeta-chain-associated protein kinase 70 (pZAP70) were analyzed by flow cytometry. Signal transducer and activator of transcription (STAT) and some inhibitory factors in T cells stimulated with anti-CD3/CD28 beads were also investigated by quantitative real-time polymerase chain reaction.

Results: Counts of CD3+, CD4+, and CD8+ T cell were significantly lower in DM than in PM (p < 0.0005). Moreover, STAT and pZAP70 expression in CD4+ T cells significantly decreased in DM (p < 0.05), whereas that in CD8+ T cells significantly increased in PM (p < 0.05) (Fig.1). Lower expression of forkhead box transcription factor (FoxP3) was also demonstrated in DM than in both PM and HC (p < 0.005). Especially in DM, a positive correlation between CD4+ T cell counts and STAT expression was detected (p < 0.05). In addition, low CD4+ T cell counts as well as reduced STAT expression were prominent in patients with interstitial lung disease (p < 0.05). STAT and pZAP70 expression significantly improved after clinical remission in both DM and PM (p < 0.05), although expression of FoxP3 remained suppressed. Besides, upregulation of suppressor of cytokine signaling-3 (SOCS3) and downregulation of interleukin 6 signal transducer (IL6ST) in CD4+ T cells were observed in both DM and PM (p < 0.05); however, no significant improvements were detected after clinical remission.

Conclusion: STAT expression and TCR-proximal signaling in CD4+ T cells were suppressed in DM, whereas those in CD8+ T cells were induced in PM, suggesting that TCR-mediated signaling may be a key pathway to determine the characteristics of peripheral blood T cells in DM and PM. Furthermore, upregulation of SOCS3 and downregulation of IL6ST and FoxP3 in CD4+ T cells cause an imbalance in intracellular signaling which may be associated with the development of DM.


Disclosure: Y. Shimojima, None; D. Kishida, None; Y. Sekijima, None.

To cite this abstract in AMA style:

Shimojima Y, Kishida D, Sekijima Y. The Characteristic T-Cell Receptor-Mediated Signaling of Peripheral Blood T Cells in Dermatomyositis and Polymyositis [abstract]. Arthritis Rheumatol. 2017; 69 (suppl 10). https://acrabstracts.org/abstract/the-characteristic-t-cell-receptor-mediated-signaling-of-peripheral-blood-t-cells-in-dermatomyositis-and-polymyositis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2017 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/the-characteristic-t-cell-receptor-mediated-signaling-of-peripheral-blood-t-cells-in-dermatomyositis-and-polymyositis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology